Daffodills Pharmaceuticals Limited

Daffodills Pharmaceuticals Limited - pharma in Meerut, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U24233UP1985PLC007205 Incorporated 28 May 1985 ROC Kanpur HQ Meerut, Uttar Pradesh, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2023
₹30.18 Cr
▲ 32% YoY
Net profit · FY 2023
₹52.19 Lakh
Net margin 1.7%
EBITDA · FY 2023
₹80.28 Lakh
EBITDA margin 2.7%
Authorised capital
₹5.5 Cr
Registered with MCA
Paid-up capital
₹3.23 Cr
Issued & subscribed
Open charges
₹16.93 Cr
Secured borrowings
Company age
41 yrs
Est. 1985
Employees · EPFO
11
Provident fund records

About Daffodills Pharmaceuticals Limited

Data last updated:

Daffodills Pharmaceuticals Limited is a public limited company based in Meerut, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 May 1985 and has been in existence for over 41 years.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP1985PLC007205. Its GSTIN is 09AAACD5022G1Z1 (Uttar Pradesh). The company holds 3 GST registrations, all of them active.

The company has an authorised share capital of ₹5.5 Cr and a paid-up capital of ₹3.23 Cr. It was formerly known as Daffodills Pharmaceutical Private Limited. It is led by directors including Prabhat Kumar Rai (Whole-Time Director) and Kunwar Krishanpal Singh (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 770/1 Soti Ganj Behind Gurudwara, Meerut, Uttar Pradesh, India – 250001.

As per the financials filed for FY 2023, the company reported a revenue of ₹30.18 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹52.19 Lakh (net margin 1.7%) and EBITDA of ₹80.28 Lakh (EBITDA margin 2.7%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 1% over five years.

The company has about 11 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Daffodills. As per MCA filings, the company has open charges of ₹16.93 Cr on record. Court records list 23 cases involving the company, including 18 filed by the company and 5 filed against it; 6 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website daffodills.in.

Company details

CIN U24233UP1985PLC007205
Registration Number 007205
Incorporation Date 28 May 1985
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Daffodills Pharmaceuticals has one previous CIN (Corporate Identification Number): L24233UP1985PLC007205. The current CIN is U24233UP1985PLC007205, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24233UP1985PLC007205Current
L24233UP1985PLC007205Previous

Contact details

Daffodills Pharmaceuticals Limited's registered office is in Meerut, Uttar Pradesh. Its website is daffodills.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    770/1 Soti Ganj Behind Gurudwara, Meerut, Uttar Pradesh, India – 250001
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Daffodills Pharmaceuticals Limited, buy the company report.

Comprehensive company report
Daffodills Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Daffodills Pharmaceuticals operates one associated brand: Daffodills. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures and exports high-quality pharmaceutical formulations for domestic and international markets.daffodills.in

Financials of Daffodills Pharmaceuticals Limited

FY 2025 filings available

Daffodills Pharmaceuticals Limited reported revenue of ₹30.18 Cr (up 32% YoY) for FY 2023.

Revenue · FY 2023
₹30.18 Cr ▲ 32%
Net profit · FY 2023
₹52.19 Lakh margin 1.7%
EBITDA · FY 2023
₹80.28 Lakh margin 2.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 32%
3 years · compounded
▼ 8%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 30%
3 years · compounded
▼ 23%
5 years · compounded
▼ 5%

Revenue rose 32% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹30.18 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹80.28 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹52.19 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin2.7%
Net Profit Margin1.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Daffodills Pharmaceuticals Limited, buy the company report.

Board of directors of Daffodills Pharmaceuticals Limited

Daffodills Pharmaceuticals has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Pranav ChaudharyDirector22 Feb 201214 Years 8 MonthsCurrent
Prateek ChaudharyDirector22 Feb 201214 Years 8 MonthsCurrent
Prabhat Kumar RaiWhole-Time Director30 Jul 20197 Years 2 MonthsCurrent
Kunwar Krishanpal SinghWhole-Time Director30 Jul 20197 Years 2 MonthsCurrent
Prashant ChaudhryDirector02 Aug 20188 Years 2 MonthsCurrent

Auditor

Daffodills Pharmaceuticals Limited is audited by MEHRA AND COMPANY for the financial year 2023.

Auditor firmFinancial yearFirm registration number
MEHRA AND COMPANYFY 2023000393C

Shareholding

The shareholding of Daffodills Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Daffodills Pharmaceuticals Limited, buy the company report.

Charges & borrowings

Open charges
₹16.93 Cr
Satisfied charges
None
Breakdown by lending institutions
Axis Bank Limited₹9.60 Cr
State Bank of India₹6.95 Cr
U. P. Financial Corporation₹0.38 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
03 Oct 2025101161572State Bank of India₹6.95 CrOpen
26 May 2025101120639Axis Bank Limited₹4.6 CrOpen
20 Sep 2018100209411Axis Bank Limited₹5 CrOpen
14 Oct 199590271772U. P. Financial Corporation₹38 LakhOpen

To see the full charge records of Daffodills Pharmaceuticals Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Daffodills Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Daffodills Pharmaceuticals Limited has a workforce of 11 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.

Employee count
11
Active EPFO establishments
1
Employee growth
10%

GST

Daffodills Pharmaceuticals has 3 GST registrations: 3 active.

Total GSTINs
3
Active
3
GSTINStateStatusRegistered on
09AAACD5022G1Z1Uttar PradeshActive01 Jul 2017
19AAACD5022G1Z0West BengalActive27 Oct 2018
36AAACD5022G1Z4TelanganaActive27 Oct 2018

To see the full GST registrations and return filing status of Daffodills Pharmaceuticals Limited, buy the company report.

Recent activity

Daffodills Pharmaceuticals Limited has 8 board changes on record since 2012: 5 appointments and 3 cessations. The latest: Kunwar Krishanpal Singh was appointed as Whole-Time Director on 30 Jul 2019.

Charges
A charge with State Bank Of India amounted to Rs. 6.95 Cr with Charge ID 101161572 was registered on 03 Oct 2025.
AGM
Daffodills Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited amounted to Rs. 4.60 Cr with Charge ID 101120639 was registered on 26 May 2025.
Filing
Daffodills Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Kunwar Krishanpal Singh was appointed as Whole-Time Director.
Appointed
Prabhat Kumar Rai was appointed as Whole-Time Director.
Charges
A charge with Axis Bank Limited of Rs. 5.00 Cr registered on 20 Sep 2018 with Charge ID 100209411 was modified on 24 Sep 2018.
Charges
A charge with Axis Bank Limited amounted to Rs. 5.00 Cr with Charge ID 100209411 was registered on 20 Sep 2018.
Ceased
Amit Dhaka ceased to be Director.
Appointed
Prashant Chaudhry was appointed as Director.
Ceased
Narender Chaudhary ceased to be Director.
Ceased
Surender Chaudhary ceased to be Director.

4 earlier events are in the company report.

Frequently asked questions

Daffodills Pharmaceuticals is an active public limited company based in Meerut, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 May 1985 (41+ years old) and is registered under CIN U24233UP1985PLC007205.

Daffodills Pharmaceuticals has 5 current directors:

The latest financial statements of Daffodills Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Daffodills Pharmaceuticals is 09AAACD5022G1Z1, registered in Uttar Pradesh. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 19AAACD5022G1Z0 (West Bengal), 36AAACD5022G1Z4 (Telangana).

The CIN (Corporate Identification Number) of Daffodills Pharmaceuticals is U24233UP1985PLC007205. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Daffodills Pharmaceuticals has 23 court cases on record: 18 filed by the company and 5 filed against it. 6 are pending. Most are in the high courts.

Daffodills Pharmaceuticals was incorporated on 28 May 1985, making it 41+ years old. It is registered with the Registrar of Companies, Kanpur.

Kunwar Krishanpal Singh was appointed as Whole-Time Director on 30 Jul 2019. Prabhat Kumar Rai was appointed as Whole-Time Director on 30 Jul 2019. Amit Dhaka ceased to be Director on 01 Sep 2018. Daffodills Pharmaceuticals has 8 board changes on record in total.

Daffodills Pharmaceuticals can be reached through the website daffodills.in. Its registered office is in Meerut, Uttar Pradesh, India.

The registered office of Daffodills Pharmaceuticals is at 7701 Soti Ganj Behind Gurudwara, Meerut, Uttar Pradesh, India – 250001.